A Phase 2 trial of NanoFlu vaccine for Influenza-virus-infections
Phase of Trial: Phase II
Latest Information Update: 09 May 2018
At a glance
- Drugs NanoFlu vaccine-Novavax (Primary)
- Indications Influenza virus infections
- Focus Pharmacodynamics
- 09 May 2018 According to a Novavax media release, top-line data from this study is expected in the first quarter of 2019.
- 05 Mar 2018 New trial record
- 28 Feb 2018 According to a Novavax media release, this trial is expected to begin in third quarter of 2018.